AR004498A1 - Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion - Google Patents
Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacionInfo
- Publication number
- AR004498A1 AR004498A1 ARP960103399A AR10339996A AR004498A1 AR 004498 A1 AR004498 A1 AR 004498A1 AR P960103399 A ARP960103399 A AR P960103399A AR 10339996 A AR10339996 A AR 10339996A AR 004498 A1 AR004498 A1 AR 004498A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- preparation
- pharmaceutical compositions
- compositions containing
- aminophosphonate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Abstract
Se describen componentes de aminofosfonato sustituídos en alfa con grupos fenol de fórmula (I) que tienen actividad de disminución de la lipoproteína(a). Se describen además composiciones farmacéuticas que los contienen, el uso de los mismos y unprocedimiento para su preparación.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH01920/95A CH690264A5 (fr) | 1995-06-30 | 1995-06-30 | Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR004498A1 true AR004498A1 (es) | 1998-12-16 |
Family
ID=4221681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960103399A AR004498A1 (es) | 1995-06-30 | 1996-06-28 | Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion |
Country Status (27)
Country | Link |
---|---|
US (2) | US6060464A (es) |
EP (1) | EP0835116A1 (es) |
JP (1) | JPH11508576A (es) |
KR (1) | KR19990028542A (es) |
CN (1) | CN1113654C (es) |
AP (1) | AP778A (es) |
AR (1) | AR004498A1 (es) |
AU (1) | AU705206B2 (es) |
BG (1) | BG102215A (es) |
BR (1) | BR9609653A (es) |
CA (1) | CA2225391A1 (es) |
CH (1) | CH690264A5 (es) |
CZ (1) | CZ422097A3 (es) |
EA (1) | EA199800106A1 (es) |
HU (1) | HUP9901684A3 (es) |
IL (1) | IL122717A0 (es) |
MA (1) | MA24340A1 (es) |
MX (1) | MX9800189A (es) |
NO (1) | NO976128L (es) |
NZ (1) | NZ312696A (es) |
OA (1) | OA10554A (es) |
PL (1) | PL187024B1 (es) |
SK (1) | SK178397A3 (es) |
TR (1) | TR199701700T1 (es) |
TW (1) | TW413681B (es) |
WO (1) | WO1997002037A1 (es) |
ZA (1) | ZA965505B (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548084B2 (en) | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
GB9626616D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626615D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
GB9626536D0 (en) * | 1996-12-20 | 1997-02-05 | Symphar Sa | Novel compounds |
DE19748659A1 (de) * | 1997-11-04 | 1999-05-06 | Hoechst Ag | Aminophosphoniumgruppen enthaltende vernetzte Copolymere für medizinische Verwendungen |
US6017918A (en) * | 1998-08-06 | 2000-01-25 | Warner-Lambert Company | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
US6284795B1 (en) | 1998-09-04 | 2001-09-04 | Warner-Lambert Company | Sulfonamide compounds and methods of treating atherosclerosis and restenosis |
AU775885B2 (en) | 1999-10-27 | 2004-08-19 | Teva Pharmaceutical Industries Ltd. | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
WO2001060805A1 (en) | 2000-02-16 | 2001-08-23 | Smithkline Beecham P.L.C. | Pyrimidine-4-one derivatives as ldl-pla2 inhibitors |
EP1320536A1 (en) | 2000-09-27 | 2003-06-25 | Ilex Oncology Research S.A. | $g(a)-SUBSTITUTED $g(b)-AMINOETHYL PHOSPHONATES |
US20030114421A1 (en) * | 2000-09-27 | 2003-06-19 | Phan Hieu Trung | Alpha-substituted beta-aminoethyl phosphonate derivatives |
GB0024808D0 (en) | 2000-10-10 | 2000-11-22 | Smithkline Beecham Plc | Novel compounds |
GB0025849D0 (en) * | 2000-10-23 | 2000-12-06 | Smithkline Beecham Plc | Novel compounds |
AU2003219701A1 (en) * | 2002-02-11 | 2003-09-04 | Ilex Products, Inc. | Alpha-substituted heteroarylalkyl phosphonate derivatives |
US20060128667A1 (en) * | 2002-05-11 | 2006-06-15 | Montes Imber F | Hydroxyphosphonates and phosphonophosphates as apolipoprotein e modulators |
JP2006501247A (ja) * | 2002-08-30 | 2006-01-12 | バイオストラタム,インコーポレイティド | ポストamadriの後生的糖化最終産物の阻害物質 |
JP5886310B2 (ja) | 2010-12-06 | 2016-03-16 | グラクソ グループ リミテッドGlaxo Group Limited | Lp−PLA2により媒介される疾患または状態の処置における使用のためのピリミジノン化合物 |
BR112014001665A2 (pt) | 2011-07-27 | 2017-02-14 | Glaxo Group Ltd | compostos de 2,3-di-hidroimidazo[1,2-c]pirimidin-5(1h)-ona utilizados como inibidores de lp-plaz |
RU2014107486A (ru) | 2011-07-27 | 2015-09-10 | Глэксо Груп Лимитед | Бициклические пиримидоновые соединения |
MY172885A (en) | 2011-09-01 | 2019-12-13 | Glaxo Group Ltd | Novel crystal form |
JP2016505053A (ja) | 2013-01-25 | 2016-02-18 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited | Lp‐PLA2の阻害剤としての二環式ピリミドン化合物 |
UY35276A (es) | 2013-01-25 | 2014-08-29 | Glaxosmithkline Ip Dev Ltd | Nuevos compuestos que inhiben la actividad de Lp-PLA2 |
WO2014114248A1 (en) | 2013-01-25 | 2014-07-31 | Glaxosmithkline Intellectual Property Development Limited | Compounds |
WO2016012916A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
WO2016012917A1 (en) | 2014-07-22 | 2016-01-28 | Glaxosmithkline Intellectual Property Development Limited | 1,2,3,5-tetrahydroimidazo[1,2-c]pyrimidine derivatives useful in the treatment of diseases and disorders mediated by lp-pla2 |
CN112778331B (zh) | 2019-11-09 | 2022-07-05 | 上海赛默罗生物科技有限公司 | 三环二氢咪唑并嘧啶酮衍生物、其制备方法、药物组合物和用途 |
CN115304620A (zh) | 2021-05-07 | 2022-11-08 | 上海赛默罗生物科技有限公司 | 嘧啶酮衍生物、其制备方法、药物组合物和用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH683996A5 (fr) * | 1992-03-05 | 1994-06-30 | Symphar Sa | Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant. |
DE4433244A1 (de) * | 1994-09-19 | 1996-03-28 | Hoechst Ag | Aminomethylphosphon- und Aminomethylphosphinsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen |
-
1995
- 1995-06-30 CH CH01920/95A patent/CH690264A5/fr not_active IP Right Cessation
-
1996
- 1996-06-26 US US08/973,669 patent/US6060464A/en not_active Expired - Fee Related
- 1996-06-26 PL PL96324341A patent/PL187024B1/pl unknown
- 1996-06-26 IL IL12271796A patent/IL122717A0/xx unknown
- 1996-06-26 WO PCT/EP1996/002842 patent/WO1997002037A1/en not_active Application Discontinuation
- 1996-06-26 CA CA002225391A patent/CA2225391A1/en not_active Abandoned
- 1996-06-26 EA EA199800106A patent/EA199800106A1/ru unknown
- 1996-06-26 HU HU9901684A patent/HUP9901684A3/hu unknown
- 1996-06-26 BR BR9609653-5A patent/BR9609653A/pt not_active Application Discontinuation
- 1996-06-26 TR TR97/01700T patent/TR199701700T1/xx unknown
- 1996-06-26 CN CN96196395A patent/CN1113654C/zh not_active Expired - Fee Related
- 1996-06-26 KR KR1019970709860A patent/KR19990028542A/ko not_active Application Discontinuation
- 1996-06-26 AU AU64185/96A patent/AU705206B2/en not_active Ceased
- 1996-06-26 CZ CZ974220A patent/CZ422097A3/cs unknown
- 1996-06-26 AP APAP/P/1997/001160A patent/AP778A/en active
- 1996-06-26 EP EP96923971A patent/EP0835116A1/en not_active Withdrawn
- 1996-06-26 MX MX9800189A patent/MX9800189A/es unknown
- 1996-06-26 SK SK1783-97A patent/SK178397A3/sk unknown
- 1996-06-26 JP JP9504801A patent/JPH11508576A/ja not_active Withdrawn
- 1996-06-26 NZ NZ312696A patent/NZ312696A/en unknown
- 1996-06-28 ZA ZA9605505A patent/ZA965505B/xx unknown
- 1996-06-28 MA MA24297A patent/MA24340A1/fr unknown
- 1996-06-28 AR ARP960103399A patent/AR004498A1/es unknown
- 1996-07-01 TW TW085107922A patent/TW413681B/zh not_active IP Right Cessation
-
1997
- 1997-12-29 NO NO976128A patent/NO976128L/no not_active Application Discontinuation
- 1997-12-30 OA OA70171A patent/OA10554A/en unknown
-
1998
- 1998-01-28 BG BG102215A patent/BG102215A/xx unknown
-
2000
- 2000-04-03 US US09/541,217 patent/US6660724B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
MA24340A1 (fr) | 1998-07-01 |
US6660724B1 (en) | 2003-12-09 |
SK178397A3 (en) | 1998-06-03 |
US6060464A (en) | 2000-05-09 |
KR19990028542A (ko) | 1999-04-15 |
IL122717A0 (en) | 1998-08-16 |
BG102215A (en) | 1998-09-30 |
PL324341A1 (en) | 1998-05-25 |
TR199701700T1 (xx) | 1998-03-21 |
CN1113654C (zh) | 2003-07-09 |
HUP9901684A2 (hu) | 1999-09-28 |
PL187024B1 (pl) | 2004-04-30 |
MX9800189A (es) | 1998-04-30 |
OA10554A (en) | 2002-05-29 |
EP0835116A1 (en) | 1998-04-15 |
EA199800106A1 (ru) | 1998-08-27 |
JPH11508576A (ja) | 1999-07-27 |
NO976128L (no) | 1998-02-10 |
ZA965505B (en) | 1998-03-30 |
CZ422097A3 (cs) | 1998-10-14 |
HUP9901684A3 (en) | 2000-04-28 |
WO1997002037A1 (en) | 1997-01-23 |
NO976128D0 (no) | 1997-12-29 |
AP778A (en) | 1999-10-29 |
CA2225391A1 (en) | 1997-01-23 |
AU705206B2 (en) | 1999-05-20 |
NZ312696A (en) | 1999-10-28 |
AU6418596A (en) | 1997-02-05 |
CN1193913A (zh) | 1998-09-23 |
BR9609653A (pt) | 1999-12-21 |
TW413681B (en) | 2000-12-01 |
AP9701160A0 (en) | 1998-01-31 |
CH690264A5 (fr) | 2000-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR004498A1 (es) | Compuestos de aminofosfonato y composiciones farmaceuticas que los contienen, el uso de los mismos, y un procedimiento para su preparacion | |
MX9204354A (es) | Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen. | |
CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
BR9713704A (pt) | Ceto-benzamida, uso da mesma, e, preparação de droga | |
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
ES2138691T3 (es) | Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina. | |
ES2079719T3 (es) | Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes. | |
ES2126766T3 (es) | 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo. | |
MX9100317A (es) | Nuevos compuestos de beta-lactama,procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
MX9204844A (es) | Derivados de benzodioxano, procedimiento para su preparacion composiciones farmaceuticas que los contienen. | |
ES2158284T3 (es) | Metil-fenil-oxazolidinonas quirales. | |
MX9207222A (es) | Procedimiento para la preparacion de compuestos farmaceuticos que reducen selectivamente el nivel de lipidos de la sangre. | |
ES2178055T3 (es) | Derivados aminicos substituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2076595T3 (es) | Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen. | |
AR033957A1 (es) | Nuevos compuestos | |
AR001051A1 (es) | Compuestos de iminooximetilenanilidas procedimiento para prepararlos composiciones que los contienenpara combatir insectos acaros y nematodos indesea bles composiciones que los contienen procedimientopara prepararlas y uso de dichos compuestos | |
IS4367A (is) | CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín | |
ES2148458T3 (es) | Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
BR9806193A (pt) | Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm | |
MX9200996A (es) | Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
AR021616A1 (es) | Cicloheptenos sustituidos, procedimiento para su preparacion y uso de los mismos. | |
MX9207264A (es) | Compuestos de sulfonimidamida, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen | |
ES2054790T3 (es) | Compuestos que tienen actividad cardiovascular. | |
AR006675A1 (es) | 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos. |